Intelligent Bio Solutions Inc. Announces Exercise of Previously Issued Warrants for $1.77 Million in Gross Proceeds

February 5, 2024

https://www.globenewswire.com/news-release/2024/02/05/2823577/0/en/Intelligent-Bio-Solutions-Inc-Announces-Exercise-of-Previously-Issued-Warrants-for-1-77-Million-in-Gross-Proceeds.html

NEW YORK, Feb. 05, 2024 (GLOBE NEWSWIRE) — Intelligent Bio Solutions Inc. (Nasdaq:INBS) (“INBS” or the “Company”), a medical technology company delivering intelligent, rapid, non-invasive testing solutions, today announced an agreement between the Company and several current warrant holders to exercise certain existing Series E Warrants (the “Existing Warrants”) to purchase up to an aggregate of 606,064 shares of common stock that were issued on October 4, 2023, in an underwritten public offering. The Existing Warrants have an exercise price of $2.9232 per share.

Read more at globenewswire.com

Related news for (INBS)

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.